Overview

An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

Status:
Completed

Trial end date:
2019-08-29

Target enrollment:

Participant gender:

Summary

This is an investigational study of experimental Medication BMS-986231 given to participants with weakened or damaged liver function.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb